Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Prostate Cancer Detection Rate of Free-Hand vs 3D Template Mapping Biopsy

Publish date:: October 25, 2019

Key clinical point: 3D template mapping detects more prostate cancer than conventional free-hand sampling.

Major finding: Template biopsy detected prostate cancer in 257/530 men and clinically-significant cancer in 196/530 men, whereas conventional biopsy detected cancer in 432/1052 men and clinically-significant cancer in 308/1,052 men.

Study details: The study included 1,052 patients who underwent conventional biopsy and 530 who underwent template biopsy with an MRI/Ultrasound fusion device.

Citation:

Zhou SR, et al. J Urol. 2019 Oct 9:101097JU0000000000000587. doi: 10.1097/JU.0000000000000587.

This Week's Must Reads

Phase II Trial of DNA Vaccine Encoding PAP in Patients with PCa ,

Utilization of Surgery for Post-prostatectomy Incontinence,

Claims Analysis of Advanced PCa Treatment Costs and Resource Use,

Testosterone Therapy Doesn't Increase Prostate Cancer Risk,

Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced PCa,

Must Reads in Prostate Cancer

Phase II Trial of DNA Vaccine Encoding PAP in Patients with PCa ,

Utilization of Surgery for Post-prostatectomy Incontinence,

Claims Analysis of Advanced PCa Treatment Costs and Resource Use,

Testosterone Therapy Doesn't Increase Prostate Cancer Risk,

Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced PCa,